HALO
Halozyme Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -5.9% ·
Aktienfluss -11.2% ·
neue Nettopositionen -6.2%
— Formel
Breite Distribution — sinkende Anteile und weniger Halter
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q1 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 132 | -2 | 91.18M | $6.60B | +5 | −6 |
| Q1 2026 | 136 | +1 | 88.77M | $5.36B | +7 | −7 |
| Q4 2025 | 135 | -1 | 97.38M | $6.16B | +1 | −1 |
| Q3 2025 | 22 | +1 | 49.86M | $3.66B | +1 | −1 |
| Q2 2025 | 19 | 0 | 43.24M | $2.25B | — | — |
| Q1 2025 | 16 | -1 | 15.61M | $996.39M | — | −1 |
| Q4 2024 | 17 | +3 | 17.59M | $840.95M | +4 | −1 |
| Q3 2024 | 13 | -1 | 6.97M | $398.81M | — | −1 |
| Q2 2024 | 14 | — | 8.14M | $426.06M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passiv) | 6.05M | -15.8% | $386.24M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (passiv) | 6.05M | -15.8% | $386.24M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passiv) | 3.17M | +3.4% | $202.27M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passiv) | 3.17M | +3.4% | $202.27M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 1.19M | -2.6% | $75.73M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 1.19M | -2.6% | $75.73M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 1.12M | +12.3% | $71.18M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 8 | Norges Bank ✦ (passiv) | 834.15K | -33.6% | $53.23M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | Capital World Investors ✦ | 748.23K | 0.0% | $47.74M | 0.0% | Held | 2 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 646.03K | +161.5% | $41.22M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 619.56K | -25.5% | $39.53M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 619.56K | -25.5% | $39.53M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 13 | Marshall Wace ✦ | 463.61K | +10374.6% | $29.58M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Marshall Wace ✦ | 463.61K | +10374.6% | $29.58M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Fisher Asset Management ✦ | 417.52K | +0.7% | $26.64M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 120.01K | +359.6% | $7.66M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 79.41K | -93.7% | $5.07M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 79.41K | -93.7% | $5.07M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Wellington Management ✦ | 53.30K | -7.1% | $3.40M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | Wellington Management ✦ | 53.30K | -7.1% | $3.40M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 21 | Wellington Management ✦ | 53.30K | -7.1% | $3.40M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 22 | Wellington Management ✦ | 53.30K | -7.1% | $3.40M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 23 | Millennium Management ✦ | 42.23K | -55.7% | $2.69M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 24 | Millennium Management ✦ | 42.23K | -55.7% | $2.69M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 33.14K | -37.4% | $2.11M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 33.14K | -37.4% | $2.11M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 33.14K | -37.4% | $2.11M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 33.14K | -37.4% | $2.11M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 33.14K | -37.4% | $2.11M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 30 | Gotham Asset Management ✦ | 32.53K | -31.4% | $2.08M | 0.0% | ▼ Trim | 4 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Point72 Asset Management | $4.06M | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 8 Inhaber, 32.79M Anteile, $43.93M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Käufe auf dem offenen Markt (P)
Keine Insider-Käufe auf dem offenen Markt in unserem Erfassungszeitraum.
Verkäufe auf dem offenen Markt (S)
Officer, Director · 9.60K Ant. · $1.03M
Officer, Director · 3.20K Ant. · $344,848
Officer, Director · 7.20K Ant. · $765,778
Officer, Director · 5.70K Ant. · $587,882
Officer, Director · 9.40K Ant. · $985,816
Officer, Director · 4.90K Ant. · $509,827
Officer, Director · 900 Ant. · $89,062
Officer, Director · 500 Ant. · $50,228
Officer, Director · 2.10K Ant. · $213,709
Officer, Director · 9.00K Ant. · $922,977
Zuteilungen, Ausübungen und Steuereinbehalte werden hier nie als Käufe oder Verkäufe gezählt. Methodik